About My Health Careers Internship MedBlogs Contact us

First Clinical Trial of Cancer Drug Apatone Shows Promising Results

by Medindia Content Team on October 7, 2007 at 1:46 PM
Font : A-A+

First Clinical Trial of Cancer Drug Apatone Shows Promising Results

A team of researchers from Summa Health System, IC-MedTech and other institutions has completed the first ever clinical trial of a drug called Apatone, with promising results in end-stage prostate cancer patients.

The researchers say that Apatone exploits a news strategy to selectively lower the level of compounds within tumour cells that assist in energy production, and protect against chemotherapy.


According to them, this non-toxic approach weakens and kills cancers in a novel way.

"This strategy targets cancer cells by their inflammatory response. It's a different approach than most other anti-tumor drugs, which target dividing cells or the development of blood vessels within the tumor. Since normal cells use sugars or fats for energy and cancer cells rely on glucose, the real key here is that Apatone resembles glucose. As Apatone preferentially accumulates in cancer cells, it also supplies quinone that weakens and can destroy the cancer cell from within," says Dr. James Jamison of Summa Health System.

"The bottom line is: Apatone selectively targets and kills tumor cells using non-toxic biochemistry that protects surrounding healthy tissue," he added.

During the trial, which began in 2005, the safety and effectiveness of the drug was examined in 17 end-stage prostate cancer patients for 12 weeks. The patients took Apatone orally each day.

The researchers monitored prostate-specific antigen (PSA) levels, PSA velocity and PSA doubling times throughout the trial.

Although PSA is a protein normally produced by the prostate gland, individuals with prostate cancer have increased levels. PSA velocity is the change of PSA levels over time and PSA doubling time is the time it takes for a patient's PSA level to double.

"The results of the trial are very promising. Sixteen of the 17 patients responded positively to the Apatone and 13 showed a decrease in PSA velocity and an increase in PSA doubling time. At the end of the treatment period, 15 patients opted to continue treatment," said Dr. Jamison.

He has also revealed that additional clinical trials have been planned for intravenous administration of Apatone in patients who have failed chemotherapy.

"Ultimately, Apatone is intended to be administered intravenously prior to chemotherapy so it can break down the substances in a tumour that protect it from the chemotherapy and allow a greater cell kill. Between cycles and following completion of chemotherapy, Apatone will be taken orally to help prevent or slow tumour regrowth," Dr. Jamison said.

The researchers have not received FDA approval for chemotherapy in conjunction with Apatone as yet.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials Cancer and Homeopathy Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Cancer Facts Cancer Placebo Effects: Rare Insights Oncology Drug Delivery Systems 

Recommended Reading
Prostate Cancer - Animation
Interactive section of Medindia gives details regarding Prostate Cancer...
Popular Therapy Opted for Treating Prostate Cancer may Augment Spread of Disease
Popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer ...
Clinical Trials
Clinical trials are experiments that yield useful information to clinicians if a particular treatmen...
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Clinical Trials - The Past and The Future
Many of the drugs that are used today have been discovered by chance or often by mere serendipity...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Oncology Drug Delivery Systems
Drug delivery in oncology offers a localized, prolonged and protected drug interaction with the canc...
Placebo Effects: Rare Insights
Placebo response is now generally well accepted. ‘Placebo response’ is the friend of the clinician a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use